MedTrace Logo

The Serum Sclerostin Levels in Cholesteatoma Patients

NCT03954288 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2019-05-21

No results posted yet for this study

Summary

The aim of this study is to investigate the levels of sclerostin in patients with cholesteatoma. So far, there is no study showing the levels of sclerostin in cholesteatoma. The investigators hope that the results of our study will start new processes that can be used in the clinic.

Conditions

  • Otitis Media Chronic
  • Cholesteatoma

Interventions

DIAGNOSTIC_TEST

serum for sclerostin ELISA test

Blood sample to measure serum sclerostin level

Sponsors & Collaborators

  • Abant Izzet Baysal University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-29
Primary Completion
2020-02-15
Completion
2020-03-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03954288 on ClinicalTrials.gov